Australia's CSL, which earlier this year paused plans to put its CSL Seqirus vaccine division up for sale, has opened the ...

Bird flu, or H5N1, has touched most of the globe, but there is one spot it hasn't reached. Researchers down under are preparing for it, but gaps in bird flu surveillance elsewhere makes it difficult.

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Moderna shares fell over 4% after the FDA signaled stricter vaccine approval rules, raising concerns about potential delays ...

Defence Minister Richard Marles has confirmed Australia is monitoring a flotilla of Chinese Navy ships currently in the ...

EQT AB and CVC Asia Pacific Ltd. scrapped talks with AUB Group Ltd. about a possible takeover offer that had valued the ...

After a rising number of Australians reported suffering from B6 toxicity, the TGA has been forced to act and remove some supplements from shelves.

Press Release - Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million Savings expected to help secure 30 million additional doses, protecting up to 7 million mo ...

Australia’s largest drugmaker CSL Ltd. is committing roughly $1.5 billion to expand its US manufacturing footprint, joining a wave of pharmaceutical giants doubling down on American production.

Shah Capital frustrated with Novavax's weak COVID-19 vaccine sales Hedge fund increases stake to 8.3%, urges sale to large pharma Novavax's COVID vaccine sales lag behind competitors Nov 13 (Reuters) ...